Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

More about this publication?
Related content
Volume 9, Number 2, February 2008

< previous issue | all issues | next issue >

Editorial

Bulletin Board

Research Report

Pharmacogenomics of metabolic effects of rosiglitazone
pp. 141-155(15)
Authors: ŠŠeda, Ondrej; ŠŠedováá, Lucie; Oliyarnyk, Olena; Kazdováá, Ludmila; Køøenováá, Drahomííra; Corbeil, Gilles; Hamet, Pavel; Tremblay, Johanne; Køøen, Vladimíír

Case--control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia
pp. 157-167(11)
Authors: Fijal, Bonnie; Ricci, Deborah; Vercammen, Els; Palmer, Peter A; Fotiou, Fotis; Fife, Daniel; Lindholm, Anders; Broderick, Erin; Francke, Stephan; Wu, Xiaodong; Colaianne, James; Cohen, Nadine

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations
pp. 169-178(10)
Authors: Wu, Alan HB; Wang, Ping; Smith, Andrew; Haller, Christine; Drake, Katherine; Linder, Mark; Valdes, Roland

Review

Genetic mutations that prevent pain: implications for future pain medication
pp. 179-194(16)
Authors: Oertel, Bruno; Löötsch, Jöörn

Psoriatic arthritis: genetic susceptibility and pharmacogenetics
pp. 195-205(11)
Authors: Rahman, Proton; O''Rielly, Darren D

Pharmacogenetic information derived from analysis of HLA alleles
pp. 207-214(8)
Authors: Gatanaga, Hiroyuki; Honda, Haruhito; Oka, Shinichi

Epigenetics of cancer progression
pp. 215-234(20)
Authors: Vucic, Emily A; Brown, Carolyn J; Lam, Wan L

Special Report

Taiwan Biobank: a project aiming to aid Taiwan''s transition into a biomedical island
pp. 235-246(12)
Authors: Fan, Chien-Te; Lin, Jui-Chu; Lee, Chung-His

Company Profile

DNAPrint Genomics, Inc.: better drugs for segmented markets
pp. 247-251(5)
Author: Frudakis, Tony

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page